Saturday, July 11, 2026

Drug profile · INN

copper cu-64 dotatate

copper cu-64 dotatate (DETECTNET) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — copper cu-64 dotatate
US status
approved
Class
Route
INTRAVENOUS
Patents
0
Programs
1
Data quality
0.84

Quick answer

copper cu-64 dotatate (DETECTNET) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN copper cu-64 dotatate
Brand DETECTNET
Mechanism Diagnostic agent
Route INTRAVENOUS
Formulation SOLUTION

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer Unknown · United Therapeutics Europe · Healthy Volunteer

Frequently asked questions

What is copper cu-64 dotatate?

copper cu-64 dotatate (DETECTNET) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for copper cu-64 dotatate?

DETECTNET is a marketed brand name for copper cu-64 dotatate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of copper cu-64 dotatate?

copper cu-64 dotatate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.